#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

CS

Athero Review - Issue 1/2026

Editorial

3

Aktualizované odporúčania ESC/EAS 2025: dyslipidémia v centre modernej kardiovaskulárnej prevencie

Guidelines

7

The position of combined treatment in the context of updated ESC/EAS recommendations for the management of dyslipidemias

Branislav Vohnout

10

Bempedoic acid in the updated recommendations for the management of dyslipidemias ESC/EAS 2025

Ľubomíra Fábryová

15

Target LDL cholesterol levels in high-risk populations in Slovakia: a retrospective study

Tibor Porubän, Dominik Pella, Daniel Pella

Reviews

23

Metabolic dysfunction associated steatotic liver disease: from pathogenesis to clinical cardio-metabolic implications

Marek Rác

33

Current view on lipoprotein(a): diagnosis and treatment

Martin Čaprnda, Matej Jantošík, Peter Kromka

41

Atherosclerosis risk and CV risk reduction in GLP1-RA treated patients

Matej Samoš

44

Patients with HIV – management of dyslipidemia, arterial hypertension, and cardiovascular risk: new challenges in the era of effective antiretroviral therapy

Matej Bendžala

50

Prevention of anthracycline-induced cardiotoxicity as a new potential indication for statins?

Beata Mladosievičová

57

Artificial intelligence in cardiovascular risk management: from digital medical history to personalized therapy

Štefan Tóth, Patrik Buček, Adriána Jarolímková, Pavol Fulop, Mariana Dvorožňáková, Tibor Porubän, Marianna Barbierik Vachalcová, Natália Vaňová

64

The impact of ultra-processed foods on dyslipidemia

Jana Lisičanová, Branislav Vohnout

From International Literature

67

Research on remarkable articles from international literature

Eva Tůmová

Annoucements

70

Rok 2025 – rok významných kardiologických studií

Athero Review

Issue 1

2026 Issue 1

Most read in this issue

#ADS_BOTTOM_SCRIPTS#